Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
Sphere Bio has raised $41.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2021.
Sphere Bio's investors include Parkwalk Advisors, Redmile Group, Sofinnova Partners, Twist Bioscience, Amadeus Capital Partners.
Sphere Bio is headquartered in Cambridge, United Kingdom.
Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
Sphere Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sphere Bio — Funding & Investors." VCBacked, October 28, 2021, https://www.vcbacked.co/company/sphere-bio. Accessed October 6, 2026.
VCBacked. (2021). Sphere Bio — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/sphere-bio
{{cite web |title=Sphere Bio — Funding & Investors |url=https://www.vcbacked.co/company/sphere-bio |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated